Arkolith/Insider Trading/ELAN/Form 4

Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR, DirectorElanco Animal Health Inc (ELAN) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)119K—$02.1M
Mar 1, 2026Tax withholding(F)230K$26.40$6.1M2.0M
Mar 1, 2026Grant(A)397K—$02.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)244K—$0244K
Mar 1, 2026Grant(A)7K—$07K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479079-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML